NTLA logo

Intellia Therapeutics (NTLA) Accounts Receivable

Annual Accounts Receivable

$8.52 M
-$27.94 M-76.64%

December 31, 2024


Summary


Performance

NTLA Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNTLAbalance sheetmetrics:

Quarterly Accounts Receivable

$8.52 M
-$337.00 K-3.81%

December 31, 2024


Summary


Performance

NTLA Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNTLAbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

NTLA Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-76.6%0.0%
3 y3 years+319.4%+319.4%
5 y5 years+84.3%+84.3%

NTLA Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-76.6%+319.4%-76.6%+372.9%
5 y5-year-76.6%+319.4%-76.6%+793.7%
alltimeall time-76.6%-100.0%-76.6%+793.7%

Intellia Therapeutics Accounts Receivable History

DateAnnualQuarterly
Dec 2024
$8.52 M(-76.6%)
$8.52 M(-3.8%)
Sep 2024
-
$8.85 M(-28.2%)
Jun 2024
-
$12.33 M(-66.2%)
Mar 2024
-
$36.43 M(-0.1%)
Dec 2023
$36.46 M(+867.5%)
$36.46 M(+461.6%)
Sep 2023
-
$6.49 M(+28.4%)
Jun 2023
-
$5.06 M(+3.1%)
Mar 2023
-
$4.91 M(+30.2%)
Dec 2022
$3.77 M(+85.5%)
$3.77 M(-6.3%)
Sep 2022
-
$4.02 M(+41.0%)
Jun 2022
-
$2.85 M(+58.5%)
Mar 2022
-
$1.80 M(-11.3%)
Dec 2021
$2.03 M(-4.6%)
$2.03 M(-18.5%)
Sep 2021
-
$2.49 M(+25.0%)
Jun 2021
-
$1.99 M(+109.1%)
Mar 2021
-
$953.00 K(-55.3%)
Dec 2020
$2.13 M
$2.13 M(+75.0%)
Sep 2020
-
$1.22 M(-68.5%)
Jun 2020
-
$3.86 M(-71.1%)
DateAnnualQuarterly
Mar 2020
-
$13.37 M(+189.4%)
Dec 2019
$4.62 M(-38.8%)
$4.62 M(+28.4%)
Sep 2019
-
$3.60 M(-14.1%)
Jun 2019
-
$4.19 M(+16.6%)
Mar 2019
-
$3.59 M(-52.4%)
Dec 2018
$7.55 M(-27.9%)
$7.55 M(+168.3%)
Sep 2018
-
$2.81 M(-67.3%)
Jun 2018
-
$8.61 M(+15.3%)
Mar 2018
-
$7.47 M(-28.7%)
Dec 2017
$10.47 M(+62.2%)
$10.47 M(+133.1%)
Sep 2017
-
$4.49 M(+62.6%)
Jun 2017
-
$2.76 M(+13.1%)
Mar 2017
-
$2.44 M(-62.1%)
Dec 2016
$6.45 M(+545.4%)
$6.45 M(+480.4%)
Sep 2016
-
$1.11 M(+11.2%)
Jun 2016
-
$1.00 M(0.0%)
Mar 2016
-
$1.00 M(0.0%)
Dec 2015
$1.00 M(>+9900.0%)
$1.00 M
Dec 2014
$0.00
-

FAQ

  • What is Intellia Therapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for Intellia Therapeutics?
  • What is Intellia Therapeutics annual accounts receivable year-on-year change?
  • What is Intellia Therapeutics quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Intellia Therapeutics?
  • What is Intellia Therapeutics quarterly accounts receivable year-on-year change?

What is Intellia Therapeutics annual accounts receivable?

The current annual accounts receivable of NTLA is $8.52 M

What is the all time high annual accounts receivable for Intellia Therapeutics?

Intellia Therapeutics all-time high annual accounts receivable is $36.46 M

What is Intellia Therapeutics annual accounts receivable year-on-year change?

Over the past year, NTLA annual accounts receivable has changed by -$27.94 M (-76.64%)

What is Intellia Therapeutics quarterly accounts receivable?

The current quarterly accounts receivable of NTLA is $8.52 M

What is the all time high quarterly accounts receivable for Intellia Therapeutics?

Intellia Therapeutics all-time high quarterly accounts receivable is $36.46 M

What is Intellia Therapeutics quarterly accounts receivable year-on-year change?

Over the past year, NTLA quarterly accounts receivable has changed by $0.00 (0.00%)